Dec. 20, 2013 -- The acquisition of water and wastewater products in the global chemical and pharmaceutical industries is expected to grow substantially within the next several years, according to recent reports published by market research organization The McIlvaine Company.

In Sedimentation & Centrifugation World Markets, research indicates that chemical manufacturers will spend $440 million in 2014 for centrifuges, clarifiers, hydrocyclones, and dissolved air flotation (DAF) systems. Further, the pharmaceutical industry demands for ultrapure water (UPW) for injection, cleaning process equipment and other uses will result in purchases close to $500 million by 2017, up from $425 million this year, as noted in Ultrapure Water: World Markets.

According to the reports, the largest growth for both sectors will be seen in Asia. The chemical industry will likely see development due to major capital expenditures for plants manufacturing basic chemicals, and the pharmaceutical industry will possibly see expansion from a construction boom centered on generic drug manufacturing. As such, major global drug companies are building generic production facilities in China, India, and other Asian countries.